Aldosterone blockade in patients with systolic left ventricular dysfunction.
Pitt
Bertram
B
University of Michigan School of Medicine, 3901 Taubman Center, Ann Arbor, Mich 48109-0366, USA.
D000450:Aldosterone / Q000502:physiology; D000077545:Eplerenone; D005544:Forecasting; D006333:Heart Failure / Q000209:etiology; D006801:Humans; D006937:Hypercholesterolemia / Q000150:complications; D006973:Hypertension / Q000150:complications; D008297:Male; D008875:Middle Aged; D000451:Mineralocorticoid Receptor Antagonists / Q000494:pharmacology / Q000627:therapeutic use*; D009203:Myocardial Infarction / Q000150:complications / Q000473:pathology; D018579:Patient Selection; D016032:Randomized Controlled Trials as Topic; D013148:Spironolactone / Q000031:analogs & derivatives* / Q000627:therapeutic use; D013599:Systole; D018487:Ventricular Dysfunction, Left / Q000150:complications / Q000188:drug therapy* / Q000503:physiopathology
D000451:Mineralocorticoid Receptor Antagonists; D013148:Spironolactone; D000450:Aldosterone; D000077545:Eplerenone